Table 2 Correlation of serum SCARNA10 levels with clinipathological parameters in HCC
Characteristics | Number (%) | Serum SCARNA10 levels | p-value | |
|---|---|---|---|---|
Low levels ≤ 3.25 (n = 65) Number (%) | High levels > 3.25 (n = 62) Number (%) | |||
Age (years) | ||||
≤ 55 | 58 (45.67) | 27 (21.26) | 31 (24.41) | 0.437 |
> 55 | 69 (54.33) | 38 (29.92) | 31 (24.41) | |
Gender | ||||
Male | 81 (63.78) | 41 (32.28) | 40 (31.50) | 0.297 |
Female | 46 (36.22) | 24 (18.90) | 22 (17.32) | |
Tumor size | ||||
≤ 5 cm | 76 (59.84) | 47 (37.01) | 29 (22.83) | < 0.01* |
> 5 cm | 51 (40.16) | 18 (14.17) | 33 (25.98) | |
Tumor number | ||||
Single | 79 (62.20) | 40 (31.50) | 39 (30.71) | 0.495 |
Multiple | 48 (37.80) | 25 (19.69) | 23 (18.11) | |
Differentiation degrees | ||||
Well | 48 (37.80) | 34 (26.77) | 14 (11.02) | < 0.01* |
Moderate | 46 (36.22) | 19 (14.96) | 27 (21.26) | |
Poor | 33 (25.98) | 12 (9.45) | 21 (16.54) | |
Tumor stage | ||||
1 | 49 (38.58) | 33 (25.98) | 16 (12.60) | < 0.01* |
2 | 49 (38.58) | 23 (18.11) | 26 (20.47) | |
3 | 19 (14.96) | 6 (4.72) | 13 (10.24) | |
4 | 10 (7.88) | 3 (2.36) | 7 (5.51) | |
Vascular invasion | ||||
Yes | 58 (45.67) | 28 (22.05) | 30 (23.62) | < 0.01* |
No | 69 (54.33) | 37 (29.13) | 32 (25.20) | |
Lymph node metastasis | ||||
Yes | 45 (35.43) | 19 (14.96) | 26 (20.47) | < 0.01* |
No | 82 (64.57) | 46 (36.22) | 36 (28.35) | |
Distant metastasis | ||||
Yes | 33 (25.98) | 18 (14.17) | 15 (11.81) | 0.038* |
No | 94 (74.02) | 47 (37.01) | 47 (37.01) | |
Complications | ||||
Yes | 47 (37.01) | 20 (15.75) | 27 (21.26) | < 0.01* |
No | 80 (62.99) | 45 (35.43) | 35 (27.56) | |